To synthesize evidence linking ApoA1/HDL depletion with endothelial injury in sepsis and evaluate the therapeutic potential of ApoA1-based interventions, emphasizing the need for further research.
Key Findings:
Reduced HDL and ApoA1 levels correlate with increased vascular permeability and endothelial dysfunction in sepsis, highlighting the need for targeted therapies.
ApoA1 serves as an independent predictor of mortality in sepsis patients, necessitating its consideration in clinical assessments.
Exogenous rHDL supplementation can protect endothelial cells and reduce inflammatory markers, suggesting a viable therapeutic pathway.
Interpretation:
The depletion of ApoA1/HDL is linked to vascular endothelial injury in sepsis, suggesting that restoring these levels may improve outcomes.
Limitations:
The review primarily focuses on observational studies; further clinical trials are needed to confirm therapeutic efficacy and safety.
Mechanistic insights into how ApoA1/HDL supplementation affects various types of sepsis are still limited, warranting more comprehensive studies.
Conclusion:
Restoring ApoA1/HDL levels through supplementation may represent a novel therapeutic approach to mitigate endothelial injury and improve sepsis outcomes.
